MorphoSys's vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Events

04. Mon
June

BIO International Convention

Boston, USA
01. Wed
August

Publication of Half-Year Report 2018

05. Mon
November

Publication of Third Quarter Interim Statement 2018

Presentations

03/13/2018
Year-End Results 2017
Planegg, Deutschland
02/15/2018
LEERINK Partners 7th Annual Global Healthcare Conference
New York, USA
01/15/2018
Kepler Cheuvreux German Corporate Conference
Frankfurt, Germany
01/10/2018
36th Annual J.P. Morgan Healthcare Conference
San Francisco, CA, USA
12/12/2017
Investor & Analyst Presentation after the 2017 ASH Annual Meeting

Corporate Communications and Investor Relations
Phone: +49 89 89927 404
Fax: +49 89 89927 5404
Email Contact